Works by Manvelian, Garen

Results: 19

Safety and efficacy of alirocumab in a real-life setting: the ODYSSEY APPRISE study.

Published in:

European Journal of Preventive Cardiology, 2021, v. 28, n. 17, p. 1864, doi. 10.1093/eurjpc/zwaa097

By:

Gaudet, Daniel;
López-Sendón, José Luis;
Averna, Maurizio;
Bigot, Grégory;
Banach, Maciej;
Letierce, Alexia;
Loy, Megan;
Samuel, Rita;
Manvelian, Garen;
Batsu, Isabela;
Henry, Patrick;
investigators, the ODYSSEY APPRISE Study

Publication type:

Article

Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial.

Published in:

European Heart Journal, 2016, v. 37, n. 48, p. 3588, doi. 10.1093/eurheartj/ehw388

By:

Moriarty, Patrick M.;
Parhofer, Klaus G.;
Babirak, Stephan P.;
Cornier, Marc-Andre;
Duell, P. Barton;
Hohenstein, Bernd;
Leebmann, Josef;
Ramlow, Wolfgang;
Schettler, Volker;
Simha, Vinaya;
Steinhagen-Thiessen, Elisabeth;
Thompson, Paul D.;
Vogt, Anja;
von Stritzky, Berndt;
Yunling Du;
Manvelian, Garen

Publication type:

Article

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment.

Published in:

2021

By:

Schwartz, Gregory G.;
Szarek, Michael;
Bittner, Vera A.;
Bhatt, Deepak L.;
Diaz, Rafael;
Goodman, Shaun G.;
Jukema, J. Wouter;
Loy, Megan;
Manvelian, Garen;
Pordy, Robert;
White, Harvey D.;
Steg, Philippe Gabriel;
Harrington, Robert A.;
Zeiher, Andreas M.;
Tricoci, Pierluigi;
Roe, Matthew T.;
Mahaffey, Kenneth W.;
Edelberg, Jay M.;
Hanotin, Corinne;
Lecorps, Guillaume

Publication type:

journal article

Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study.

Published in:

2016

By:

Stroes, Erik;
Guyton, John R.;
Lepor, Norman;
Civeira, Fernando;
Gaudet, Daniel;
Watts, Gerald F.;
Baccara‐Dinet, Marie T.;
Lecorps, Guillaume;
Manvelian, Garen;
Farnier, Michel;
Kostner, K.;
Lehman, S.;
Descamps, O.;
Gheyle, L.;
Mathieu, C.;
Bergeron, J.;
Elliott, T.;
Girard, G.;
Gupta, A.;
Hoag, G.

Publication type:

journal article

Correction: Effect of alirocumab on cataracts in patients with acute coronary syndromes.

Published in:

2023

By:

Suc, Gaspard;
Schwartz, Gregory G.;
Goodman, Shaun G.;
Jukema, J. Wouter;
Manvelian, Garen;
Poulouin, Yann;
Pordy, Robert;
Scemama, Michel;
Szarek, Michael;
Steg, Ph.Gabriel

Publication type:

Correction Notice

Effect of alirocumab on cataracts in patients with acute coronary syndromes.

Published in:

BMC Ophthalmology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12886-023-03012-1

By:

Suc, Gaspard;
Schwartz, Gregory G.;
Goodman, Shaun G.;
Jukema, J. Wouter;
Manvelian, Garen;
Poulouin, Yann;
Pordy, Robert;
Scemama, Michel;
Szarek, Michael;
Steg, Ph. Gabriel

Publication type:

Article

Effect of alirocumab on cataracts in patients with acute coronary syndromes.

Published in:

BMC Ophthalmology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12886-023-03012-1

By:

Suc, Gaspard;
Schwartz, Gregory G.;
Goodman, Shaun G.;
Jukema, J. Wouter;
Manvelian, Garen;
Poulouin, Yann;
Pordy, Robert;
Scemama, Michel;
Szarek, Michael;
Steg, Ph. Gabriel

Publication type:

Article

Long-Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5Years of Placebo-Controlled Observation in the ODYSSEY OUTCOMES Tria.

Published in:

Journal of the American Heart Association, 2023, v. 12, n. 18, p. 1, doi. 10.1161/JAHA.122.029216

By:

Goodman, Shaun G.;
Steg, Philippe Gabriel;
Poulouin, Yann;
Bhatt, Deepak L.;
Bittner, Vera A.;
Diaz, Rafael;
Garon, Genevieve;
Harrington, Robert A.;
Jukema, J. Wouter;
Manvelian, Garen;
Stipek, Wanda;
Szarek, Michael;
White, Harvey D.;
Schwartz, Gregory G.

Publication type:

Article

Effect of proprotein convertase subtilisin/kexin type 9 inhibition on cancer events: A pooled, post hoc, competing risk analysis of alirocumab clinical trials.

Published in:

Cancer Medicine, 2023, v. 12, n. 16, p. 16859, doi. 10.1002/cam4.6310

By:

Mohammadi, Kusha A.;
Brackin, Taylor;
Schwartz, Gregory G.;
Steg, Philippe Gabriel;
Szarek, Michael;
Manvelian, Garen;
Pordy, Robert;
Fazio, Sergio;
Geba, Gregory P.

Publication type:

Article

Pharmacokinetics of extended-release epidural morphine sulfate: Pooled analysis of six clinical studies.

Published in:

American Journal of Health-System Pharmacy, 2009, v. 66, n. 11, p. 1020, doi. 10.2146/ajhp080154

By:

Viscusi, Eugene R.;
Gambling, David R.;
Hughes, Thomas L.;
Manvelian, Garen Z.

Publication type:

Article

Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial.

Published in:

Annals of Neurology, 2009, v. 66, n. 1, p. 28, doi. 10.1002/ana.21723

By:

Molina, Carlos A.;
Barreto, Andrew D.;
Tsivgoulis, Georgios;
Sierzenski, Paul;
Malkoff, Marc D.;
Rubiera, Marta;
Gonzales, Nicole;
Mikulik, Robert;
Pate, Greg;
Ostrem, James;
Singleton, Walter;
Manvelian, Garen;
Unger, Evan C.;
Grotta, James C.;
Schellinger, Peter D.;
Alexandrov, Andrei V.

Publication type:

Article

Treatment adherence and effect of concurrent statin intensity on the efficacy and safety of alirocumab in a real-life setting: results from ODYSSEY APPRISE.

Published in:

2022

By:

Banach, Maciej;
López-Sendon, José Luis;
Averna, Maurizio;
Cariou, Bertrand;
Loy, Megan;
Manvelian, Garen;
Batsu, Isabela;
Poulouin, Yann;
Gaudet, Daniel

Publication type:

journal article

Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial.

Published in:

European Heart Journal, 2023, v. 44, n. 16, p. 1408, doi. 10.1093/eurheartj/ehad144

By:

Schwartz, Gregory G;
Szarek, Michael;
Bhatt, Deepak L;
Bittner, Vera A;
Bujas-Bobanovic, Maja;
Diaz, Rafael;
Fazio, Sergio;
Fras, Zlatko;
Goodman, Shaun G;
Harrington, Robert A;
Jukema, J Wouter;
Manvelian, Garen;
Pordy, Robert;
Ray, Kausik K;
Scemama, Michel;
White, Harvey D;
Steg, Ph Gabriel;
Investigators, for the ODYSSEY OUTCOMES

Publication type:

Article

No evidence of neurocognitive adverse events associated with alirocumab treatment in 3340 patients from 14 randomized Phase 2 and 3 controlled trials: ameta-analysis of individual patient data.

Published in:

European Heart Journal, 2018, v. 39, n. 5, p. 374, doi. 10.1093/eurheartj/ehx661

By:

Harvey, Philip D;
Sabbagh, Marwan N;
Harrison, John E;
Ginsberg, Henry N;
Chapman, M John;
Manvelian, Garen;
Moryusef, Angele;
Mandel, Jonas;
Farnier, Michel

Publication type:

Article

PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia.

Published in:

European Heart Journal, 2017, v. 38, n. 20, p. 1548, doi. 10.1093/eurheartj/ehx002

By:

Moens, Sophie J. Bernelot;
Neele, Annette E.;
Kroon, Jeffrey;
van der Valk, Fleur M.;
Van den Bossche, Jan;
Hoeksema, Marten A.;
Hoogeveen, Renate M.;
Schnitzler, Johan G.;
Baccara-Dinet, Marie T.;
Manvelian, Garen;
de Winther, Menno P. J.;
Stroes, Erik S. G.

Publication type:

Article

Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study.

Published in:

Cardiovascular Drugs & Therapy, 2020, v. 34, n. 4, p. 515, doi. 10.1007/s10557-020-06984-0

By:

Langslet, Gisle;
Hovingh, G. Kees;
Guyton, John R.;
Baccara-Dinet, Marie T.;
Letierce, Alexia;
Manvelian, Garen;
Farnier, Michel

Publication type:

Article

The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability.

Published in:

Cardiovascular Drugs & Therapy, 2017, v. 31, n. 2, p. 179, doi. 10.1007/s10557-017-6723-4

By:

Rosenson, Robert;
Miller, Kate;
Bayliss, Martha;
Sanchez, Robert;
Baccara-Dinet, Marie;
Chibedi-De-Roche, Daniela;
Taylor, Beth;
Khan, Irfan;
Manvelian, Garen;
White, Michelle;
Jacobson, Terry

Publication type:

Article

Alirocumab in Pediatric Patients With Heterozygous Familial Hypercholesterolemia: A Randomized Clinical Trial.

Published in:

JAMA Pediatrics, 2024, v. 178, n. 3, p. 283, doi. 10.1001/jamapediatrics.2023.6477

By:

Santos, Raul D.;
Wiegman, Albert;
Caprio, Sonia;
Cariou, Bertrand;
Averna, Maurizio;
Poulouin, Yann;
Scemama, Michel;
Manvelian, Garen;
Garon, Genevieve;
Daniels, Stephen

Publication type:

Article

Efficacy and Safety of Alirocumab 300 mg Every 4 Weeks in Individuals With Type 2 Diabetes on Maximally Tolerated Statin.

Published in:

2019

By:

Müller-Wieland, Dirk;
Rader, Daniel J;
Moriarty, Patrick M;
Bergeron, Jean;
Langslet, Gisle;
Ray, Kausik K;
Manvelian, Garen;
Thompson, Desmond;
Bujas-Bobanovic, Maja;
Roth, Eli M

Publication type:

journal article